Cite
Knepper TC, Panchaud RA, Muradova E, et al. An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response. Cancer Med. 2021;10(17):5889-5896doi: 10.1002/cam4.4138.
Knepper, T. C., Panchaud, R. A., Muradova, E., Cohen, L., DeCaprio, J. A., Khushalani, N. I., Tsai, K. Y., & Brohl, A. S. (2021). An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response. Cancer medicine, 10(17), 5889-5896. https://doi.org/10.1002/cam4.4138
Knepper, Todd C, et al. "An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response." Cancer medicine vol. 10,17 (2021): 5889-5896. doi: https://doi.org/10.1002/cam4.4138
Knepper TC, Panchaud RA, Muradova E, Cohen L, DeCaprio JA, Khushalani NI, Tsai KY, Brohl AS. An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response. Cancer Med. 2021 Sep;10(17):5889-5896. doi: 10.1002/cam4.4138. Epub 2021 Jul 16. PMID: 34269527; PMCID: PMC8419775.
Copy
Download .nbib
